ExplainabilityBiasFairnesscs.CV
VR-FuseNet: A Fusion of Heterogeneous Fundus Data and Explainable Deep Network for Diabetic Retinopathy Classification
Shamim Rahim Refat, Ziyan Shirin Raha, Shuvashis Sarker, Faika Fairuj Preotee, MD. Musfikur Rahman, Tashreef Muhammad, Mohammad Shafiul Alam
April 30, 2025
Biomedical Materials & Devices
17 citations
2 influential
Key Takeaways
-
Combining multiple datasets improves AI reliability: The researchers merged five publicly available diabetic retinopathy datasets to address real-world challenges like dataset imbalance and limited diversity, demonstrating that hybrid datasets can help AI models generalize better to different patient populations and imaging conditions.
-
Data preprocessing techniques are essential for fairness: The study applied specific preprocessing methods (SMOTE for class balancing and CLAHE for image enhancement) to systematically address imbalanced data, which is critical for ensuring the AI system performs equitably across different severity levels of the disease rather than favoring common cases.
-
Hybrid AI models outperform single approaches: VR-FuseNet combined two different neural network architectures (VGG19 and ResNet50V2) and achieved 91.824% accuracy, outperforming either architecture alone—suggesting that responsible AI development benefits from thoughtfully combining complementary technologies rather than relying on single solutions.
-
Explainability matters for medical AI deployment: The paper emphasizes "explainable deep networks" in its title and approach, reflecting the importance of making AI diagnostic decisions interpretable to clinicians, which is crucial for building trust and enabling doctors to validate or question the system's recommendations in clinical practice.
-
Automated detection addresses healthcare equity: By developing efficient automated methods for early diabetic retinopathy detection, this work aims to improve access to screening in resource-limited settings where ophthalmologists may be scarce, potentially reducing vision loss disparities among diabetic patients.